Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 58

1.

Diffusion tensor imaging of the normal-appearing deep gray matter in primary and secondary progressive multiple sclerosis.

Woitek R, Leutmezer F, Dal-Bianco A, Furtner J, Kasprian G, Prayer D, Schöpf V.

Acta Radiol. 2019 Jun 6:284185119852735. doi: 10.1177/0284185119852735. [Epub ahead of print]

PMID:
31169410
2.

Real-life use of oral disease-modifying treatments in Austria.

Guger M, Enzinger C, Leutmezer F, Kraus J, Kalcher S, Kvas E, Berger T; Austrian MS Treatment Registry (AMSTR).

Acta Neurol Scand. 2019 Jul;140(1):32-39. doi: 10.1111/ane.13097. Epub 2019 Apr 22.

PMID:
30958901
3.

TPP2 mutation associated with sterile brain inflammation mimicking MS.

Reinthaler EM, Graf E, Zrzavy T, Wieland T, Hotzy C, Kopecky C, Pferschy S, Schmied C, Leutmezer F, Keilani M, Lill CM, Hoffjan S, Epplen JT, Zettl UK, Hecker M, Deutschländer A, Meuth SG, Ahram M, Mustafa B, El-Khateeb M, Vilariño-Güell C, Sadovnick AD, Zimprich F, Tomkinson B, Strom T, Kristoferitsch W, Lassmann H, Zimprich A.

Neurol Genet. 2018 Nov 13;4(6):e285. doi: 10.1212/NXG.0000000000000285. eCollection 2018 Dec.

4.

A rare P2RX7 variant in a Hungarian family with multiple sclerosis.

Zrzavy T, Kovacs-Nagy R, Reinthaler E, Deutschländer A, Schmied C, Kornek B, Leutmezer F, Zimprich A.

Mult Scler Relat Disord. 2019 Jan;27:340-341. doi: 10.1016/j.msard.2018.10.110. Epub 2018 Oct 27. No abstract available.

PMID:
30472412
5.

Month-of-birth-effect in multiple sclerosis in Austria.

Walleczek NK, Frommlet F, Bsteh G, Eggers C, Rauschka H, Koppi S, Assar H, Ehling R, Birkl C, Salhofer-Polanyi S, Baumgartner A, Blechinger S, Buchinger D, Sellner J, Kraus J, Moser H, Mayr M, Guger M, Rathmaier S, Raber B, Liendl H, Hiller MS, Parigger S, Morgenstern G, Kempf I, Spiss HK, Meister B, Heine M, Cisar A, Bachler H, Khalil M, Fuchs S, Enzinger C, Fazekas F, Leutmezer F, Berger T, Kristoferitsch W, Aboulenein-Djamshidian F.

Mult Scler. 2018 Nov 22:1352458518810924. doi: 10.1177/1352458518810924. [Epub ahead of print]

PMID:
30463473
6.

Do elevated autoantibodies in patients with multiple sclerosis matter?

Dal-Bianco A, Wenhoda F, Rommer PS, Weber M, Altmann P, Kraus J, Leutmezer F, Salhofer-Polanyi S.

Acta Neurol Scand. 2019 Mar;139(3):238-246. doi: 10.1111/ane.13054. Epub 2018 Dec 3.

PMID:
30447159
7.

7 T Magnetic Resonance Spectroscopic Imaging in Multiple Sclerosis: How Does Spatial Resolution Affect the Detectability of Metabolic Changes in Brain Lesions?

Heckova E, Strasser B, Hangel GJ, Považan M, Dal-Bianco A, Rommer PS, Bednarik P, Gruber S, Leutmezer F, Lassmann H, Trattnig S, Bogner W.

Invest Radiol. 2019 Apr;54(4):247-254. doi: 10.1097/RLI.0000000000000531.

PMID:
30433892
8.

Clinical and magnetic resonance imaging features of children, adolescents, and adults with a clinically isolated syndrome.

Milos RI, Szimacsek M, Leutmezer F, Rostasy K, Blaschek A, Karenfort M, Schimmel M, Pritsch M, Storm Van's Gravesande K, Weber M, Schmoeger M, Seidl R, Prayer D, Kornek B.

Eur J Paediatr Neurol. 2018 Nov;22(6):1087-1094. doi: 10.1016/j.ejpn.2018.08.003. Epub 2018 Aug 28.

PMID:
30195407
9.

Health-related quality of life in multiple sclerosis: temperament outweighs EDSS.

Salhofer-Polanyi S, Friedrich F, Löffler S, Rommer PS, Gleiss A, Engelmaier R, Leutmezer F, Vyssoki B.

BMC Psychiatry. 2018 May 23;18(1):143. doi: 10.1186/s12888-018-1719-6.

10.

Management of multiple sclerosis patients in central European countries: current needs and potential solutions.

Berger T, Adamczyk-Sowa M, Csépány T, Fazekas F, Hojs Fabjan T, Horáková D, Illes Z, Klimová E, Leutmezer F, Rejdak K, Rozsa C, Šega Jazbec S, Szilasiová J, Turčáni P, Vachová M, Vécsei L, Havrdová E.

Ther Adv Neurol Disord. 2018 Feb 22;11:1756286418759189. doi: 10.1177/1756286418759189. eCollection 2018. Review.

11.

Real-life clinical use of natalizumab and fingolimod in Austria.

Guger M, Enzinger C, Leutmezer F, Kraus J, Kalcher S, Kvas E, Berger T.

Acta Neurol Scand. 2018 Feb;137(2):181-187. doi: 10.1111/ane.12864. Epub 2017 Nov 20.

PMID:
29159801
12.

Epidemiology of Multiple Sclerosis in Austria.

Salhofer-Polanyi S, Cetin H, Leutmezer F, Baumgartner A, Blechinger S, Dal-Bianco A, Altmann P, Bajer-Kornek B, Rommer P, Guger M, Leitner-Bohn D, Reichardt B, Alasti F, Temsch W, Stamm T.

Neuroepidemiology. 2017;49(1-2):40-44. doi: 10.1159/000479696. Epub 2017 Aug 19.

PMID:
28848208
13.

Treatment of the First Acute Relapse Following Therapeutic Plasma Exchange in Formerly Glucocorticosteroid-Unresponsive Multiple Sclerosis Patients-A Multicenter Study to Evaluate Glucocorticosteroid Responsiveness.

Ehler J, Blechinger S, Rommer PS, Koball S, Mitzner S, Hartung HP, Leutmezer F, Sauer M, Zettl UK.

Int J Mol Sci. 2017 Aug 11;18(8). pii: E1749. doi: 10.3390/ijms18081749.

14.

Slow expansion of multiple sclerosis iron rim lesions: pathology and 7 T magnetic resonance imaging.

Dal-Bianco A, Grabner G, Kronnerwetter C, Weber M, Höftberger R, Berger T, Auff E, Leutmezer F, Trattnig S, Lassmann H, Bagnato F, Hametner S.

Acta Neuropathol. 2017 Jan;133(1):25-42. doi: 10.1007/s00401-016-1636-z. Epub 2016 Oct 27.

15.

Aquaporin 4-specific T cells and NMO-IgG cause primary retinal damage in experimental NMO/SD.

Zeka B, Hastermann M, Kaufmann N, Schanda K, Pende M, Misu T, Rommer P, Fujihara K, Nakashima I, Dahle C, Leutmezer F, Reindl M, Lassmann H, Bradl M.

Acta Neuropathol Commun. 2016 Aug 8;4(1):82. doi: 10.1186/s40478-016-0355-y.

16.

Characterization of the binding pattern of human aquaporin-4 autoantibodies in patients with neuromyelitis optica spectrum disorders.

Tuller F, Holzer H, Schanda K, Aboulenein-Djamshidian F, Höftberger R, Khalil M, Seifert-Held T, Leutmezer F, Berger T, Reindl M.

J Neuroinflammation. 2016 Jul 1;13(1):176. doi: 10.1186/s12974-016-0642-3.

17.

Highly encephalitogenic aquaporin 4-specific T cells and NMO-IgG jointly orchestrate lesion location and tissue damage in the CNS.

Zeka B, Hastermann M, Hochmeister S, Kögl N, Kaufmann N, Schanda K, Mader S, Misu T, Rommer P, Fujihara K, Illes Z, Leutmezer F, Sato DK, Nakashima I, Reindl M, Lassmann H, Bradl M.

Acta Neuropathol. 2015 Dec;130(6):783-98. doi: 10.1007/s00401-015-1501-5. Epub 2015 Nov 3.

18.

Veins in plaques of multiple sclerosis patients - a longitudinal magnetic resonance imaging study at 7 Tesla.

Dal-Bianco A, Hametner S, Grabner G, Schernthaner M, Kronnerwetter C, Reitner A, Vass C, Kircher K, Auff E, Leutmezer F, Vass K, Trattnig S.

Eur Radiol. 2015 Oct;25(10):2913-20. doi: 10.1007/s00330-015-3719-y. Epub 2015 Apr 23.

PMID:
25903703
19.

Elevated levels of carbonyl proteins in cerebrospinal fluid of patients with neurodegenerative diseases.

Rommer PS, Greilberger J, Salhofer-Polanyi S, Auff E, Leutmezer F, Herwig R.

Tohoku J Exp Med. 2014 Dec;234(4):313-7. doi: 10.1620/tjem.234.313.

20.

Celiac disease with cerebral and peripheral nerve involvement mimicking multiple sclerosis.

Finsterer J, Leutmezer F.

J Med Life. 2014 Sep 15;7(3):440-4. Epub 2014 Sep 25.

21.

Secretomes of apoptotic mononuclear cells ameliorate neurological damage in rats with focal ischemia.

Altmann P, Mildner M, Haider T, Traxler D, Beer L, Ristl R, Golabi B, Gabriel C, Leutmezer F, Ankersmit HJ.

Version 2. F1000Res. 2014 Jun 19 [revised 2014 Jan 1];3:131. doi: 10.12688/f1000research.4219.2. eCollection 2014.

22.

[Contribution of spinal cord biopsy to the differential diagnosis of longitudinal extensive transverse myelitis].

Ringelstein M, Aktas O, Harmel J, Prayer D, Jarius S, Wildemann B, Hartung HP, Salhofer-Polanyi S, Leutmezer F, Rommer PS.

Nervenarzt. 2014 Oct;85(10):1298-303. doi: 10.1007/s00115-014-4137-0. Review. German.

PMID:
25148869
23.

Contemporary treatment options for relapsing-remitting multiple sclerosis.

Salhofer-Polanyi S, Leutmezer F.

Drugs Today (Barc). 2014 May;50(5):365-83. doi: 10.1358/dot.2014.50.5.2132741. Review.

PMID:
24918837
24.

What to expect after natalizumab cessation in a real-life setting.

Salhofer-Polanyi S, Baumgartner A, Kraus J, Maida E, Schmied M, Leutmezer F.

Acta Neurol Scand. 2014 Aug;130(2):97-102. doi: 10.1111/ane.12250. Epub 2014 Apr 10.

PMID:
24720783
25.

Neuromyelitis optica in Austria in 2011: to bridge the gap between neuroepidemiological research and practice in a study population of 8.4 million people.

Aboul-Enein F, Seifert-Held T, Mader S, Kuenz B, Lutterotti A, Rauschka H, Rommer P, Leutmezer F, Vass K, Flamm-Horak A, Stepansky R, Lang W, Fertl E, Schlager T, Heller T, Eggers C, Safoschnik G, Fuchs S, Kraus J, Assar H, Guggenberger S, Reisz M, Schnabl P, Komposch M, Simschitz P, Skrobal A, Moser A, Jeschow M, Stadlbauer D, Freimüller M, Guger M, Schmidegg S, Franta C, Weiser V, Koppi S, Niederkorn-Duft M, Raber B, Schmeissner I, Jecel J, Tinchon A, Storch MK, Reindl M, Berger T, Kristoferitsch W.

PLoS One. 2013 Nov 5;8(11):e79649. doi: 10.1371/journal.pone.0079649. eCollection 2013.

26.

Benefits of inpatient multidisciplinary rehabilitation in multiple sclerosis.

Salhofer-Polanyi S, Windt J, Sumper H, Grill H, Essmeister M, Diermayr G, Zebenholzer K, Leutmezer F, Zulehner G, Vass K, Asenbaum-Nan S.

NeuroRehabilitation. 2013;33(2):285-92. doi: 10.3233/NRE-130956.

PMID:
23949063
27.

Exploratory investigation of eight circulating plasma markers in brain tumor patients.

Ilhan-Mutlu A, Wagner L, Widhalm G, Wöhrer A, Bartsch S, Czech T, Heinzl H, Leutmezer F, Prayer D, Marosi C, Base W, Preusser M.

Neurosurg Rev. 2013 Jan;36(1):45-55; discussion 55-6. doi: 10.1007/s10143-012-0401-6. Epub 2012 Jul 5.

PMID:
22763625
28.

Replication study of multiple sclerosis (MS) susceptibility alleles and correlation of DNA-variants with disease features in a cohort of Austrian MS patients.

Schmied MC, Zehetmayer S, Reindl M, Ehling R, Bajer-Kornek B, Leutmezer F, Zebenholzer K, Hotzy C, Lichtner P, Meitinger T, Wichmann HE, Illig T, Gieger C, Huber K, Khalil M, Fuchs S, Schmidt H, Auff E, Kristoferitsch W, Fazekas F, Berger T, Vass K, Zimprich A.

Neurogenetics. 2012 May;13(2):181-7. doi: 10.1007/s10048-012-0316-y. Epub 2012 Mar 14.

PMID:
22411505
29.

A novel mutation in the MFSD8 gene in late infantile neuronal ceroid lipofuscinosis.

Stogmann E, El Tawil S, Wagenstaller J, Gaber A, Edris S, Abdelhady A, Assem-Hilger E, Leutmezer F, Bonelli S, Baumgartner C, Zimprich F, Strom TM, Zimprich A.

Neurogenetics. 2009 Feb;10(1):73-7. doi: 10.1007/s10048-008-0153-1. Epub 2008 Oct 11.

PMID:
18850119
30.

Brain natriuretic peptide correlates with the extent of atrial fibrillation-associated silent brain lesions.

Gartner W, Zierhut B, Mineva I, Sodeck G, Leutmezer F, Domanovits H, Prayer D, Wolf F, Base W, Weissel M, Wagner L.

Clin Biochem. 2008 Dec;41(18):1434-9. doi: 10.1016/j.clinbiochem.2008.09.096. Epub 2008 Sep 18.

PMID:
18823968
31.

Disruption of nigrostriatal and cerebellothalamic pathways in dopamine responsive Holmes' tremor.

Seidel S, Kasprian G, Leutmezer F, Prayer D, Auff E.

J Neurol Neurosurg Psychiatry. 2009 Aug;80(8):921-3. doi: 10.1136/jnnp.2008.146324. Epub 2008 May 1.

PMID:
18450789
32.

Idiopathic generalized epilepsy phenotypes associated with different EFHC1 mutations.

Stogmann E, Lichtner P, Baumgartner C, Bonelli S, Assem-Hilger E, Leutmezer F, Schmied M, Hotzy C, Strom TM, Meitinger T, Zimprich F, Zimprich A.

Neurology. 2006 Dec 12;67(11):2029-31.

PMID:
17159113
33.

Mutations in the CLCN2 gene are a rare cause of idiopathic generalized epilepsy syndromes.

Stogmann E, Lichtner P, Baumgartner C, Schmied M, Hotzy C, Asmus F, Leutmezer F, Bonelli S, Assem-Hilger E, Vass K, Hatala K, Strom TM, Meitinger T, Zimprich F, Zimprich A.

Neurogenetics. 2006 Nov;7(4):265-8. Epub 2006 Aug 24.

PMID:
16932951
34.

Postictal paresis in focal epilepsies--incidence, duration, and causes: a video-EEG monitoring study.

Gallmetzer P, Leutmezer F, Serles W, Assem-Hilger E, Spatt J, Baumgartner C.

Neurology. 2004 Jun 22;62(12):2160-4.

PMID:
15210875
35.

Postictal psychosis in temporal lobe epilepsy.

Leutmezer F, Podreka I, Asenbaum S, Pietrzyk U, Lucht H, Back C, Benda N, Baumgartner C.

Epilepsia. 2003 Apr;44(4):582-90.

36.

Electrocardiographic changes at the onset of epileptic seizures.

Leutmezer F, Schernthaner C, Lurger S, Pötzelberger K, Baumgartner C.

Epilepsia. 2003 Mar;44(3):348-54.

37.

Asymmetric ending of secondarily generalized seizures: a lateralizing sign in TLE.

Leutmezer F, Wöginger S, Antoni E, Seidl B, Baumgartner C.

Neurology. 2002 Oct 22;59(8):1252-4.

PMID:
12391358
38.

Serum s-100 protein is not a suitable seizure marker in temporal lobe epilepsy.

Leutmezer F, Wagner O, Baumgartner C.

Epilepsia. 2002 Oct;43(10):1172-4.

39.

Focal features in patients with idiopathic generalized epilepsy.

Leutmezer F, Lurger S, Baumgartner C.

Epilepsy Res. 2002 Aug;50(3):293-300.

PMID:
12200220
40.

Regulation of cytokine production in human peripheral blood mononuclear cells and allergen-specific th cell clones by 1alpha,25-dihydroxyvitamin D3.

Rausch-Fan X, Leutmezer F, Willheim M, Spittler A, Bohle B, Ebner C, Jensen-Jarolim E, Boltz-Nitulescu G.

Int Arch Allergy Immunol. 2002 May;128(1):33-41.

PMID:
12037399
41.

Postictal signs of lateralizing and localizing significance.

Leutmezer F, Baumgartner C.

Epileptic Disord. 2002 Mar;4(1):43-8.

42.

Autonomic symptoms during epileptic seizures.

Baumgartner C, Lurger S, Leutmezer F.

Epileptic Disord. 2001 Sep;3(3):103-16. Review.

43.

Ictal urinary urge indicates seizure onset in the nondominant temporal lobe.

Baumgartner C, Gröppel G, Leutmezer F, Aull-Watschinger S, Pataraia E, Feucht M, Trinka E, Unterberger I, Bauer G.

Neurology. 2000 Aug 8;55(3):432-4.

PMID:
10932282
44.

Regional cerebral blood flow during temporal lobe seizures associated with ictal vomiting: an ictal SPECT study in two patients.

Baumgartner C, Olbrich A, Lindinger G, Pataraia E, Gröppel G, Bacher J, Aull S, Serles W, Hoffmann M, Leutmezer F, Czech T, Prayer D, Pietrzyk U, Asenbaum S, Podreka I.

Epilepsia. 1999 Aug;40(8):1085-91.

45.

Clinical symptoms in psychogenic seizures.

Gröppel G, Pataraia E, Olbrich A, Bacher J, Leutmezer F, Aull S, Kapitany T, Lehrner J, Lindinger G, Baumgartner C.

Wien Klin Wochenschr. 1999 Jun 18;111(12):469-75.

PMID:
10420505
46.

A case of startle epilepsy and SSMA seizures documented with subdural recordings.

Serles W, Leutmezer F, Pataraia E, Olbrich A, Gröppel G, Czech T, Baumgartner C.

Epilepsia. 1999 Jul;40(7):1031-5.

47.

Health-related quality of life (HRQOL), activity of daily living (ADL) and depressive mood disorder in temporal lobe epilepsy patients.

Lehrner J, Kalchmayr R, Serles W, Olbrich A, Pataraia E, Aull S, Bacher J, Leutmezer F, Gröppel G, Deecke L, Baumgartner C.

Seizure. 1999 Apr;8(2):88-92.

48.

Genital automatisms in complex partial seizures.

Leutmezer F, Serles W, Bacher J, Gröppel G, Pataraia E, Aull S, Olbrich A, Czech T, Baumgartner C.

Neurology. 1999 Apr 12;52(6):1188-91.

PMID:
10214741
49.

Postictal nose wiping: a lateralizing sign in temporal lobe complex partial seizures.

Leutmezer F, Serles W, Lehrner J, Pataraia E, Zeiler K, Baumgartner C.

Neurology. 1998 Oct;51(4):1175-7.

PMID:
9781551
50.

Effects of dental amalgam and heavy metal cations on cytokine production by peripheral blood mononuclear cells in vitro.

Schedle A, Rausch-Fan XH, Samorapoompichit P, Franz A, Leutmezer F, Spittler A, Baghestanian M, Lucas T, Valent P, Slavicek R, Boltz-Nitulescu G.

J Biomed Mater Res. 1998 Oct;42(1):76-84.

PMID:
9740009

Supplemental Content

Loading ...
Support Center